Vimarsana
Biggest News Aggregation in the World

Page 8 - Alembic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alembic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alembic Today - Breaking & Trending Today

Alembic partner's anti blood cancer drug gets U.S. FDA nod - Vimarsana News

Alembic partner's anti blood cancer drug gets U.S. FDA nod

Updated: Share Article AAA Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its novel, next generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood cancer. The drug, which has been licensed to TG Therapeutics since 2012, has bagged the approval for the U.S. market. TG Therapeutics has the global license except for the Indian market which will be handled by Rhizen and Alembic. The...

USFDA concludes inspection of Alembic Pharma's Karkhadi facility - Vimarsana News

USFDA concludes inspection of Alembic Pharma's Karkhadi facility

With five observations Alembic Pharmaceuticals announced that United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals' New Injectable Facility (F-3) located at Karkhadi from 29 January 2021 to 5 February 2021. This was a scheduled inspection and at the end of the inspection, the USFDA issued a Form 483 with 5 observations. Powered by Capital Market - Live News (This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) Dear Reader, Business Standard has always strived hard to provide up-to-date in...

Alembic consolidated net profit rises 25.81% in the December 2020 quarter - Vimarsana News

Alembic consolidated net profit rises 25.81% in the December 2020 quarter

Read more about Alembic consolidated net profit rises 25.81% in the December 2020 quarter on Business Standard. Sales rise 13.48% to Rs 14.48 crore

Adani Green share price: Stocks in the news: Adani Green, YES Bank, ICICI Lombard & Mindtree - Vimarsana News

Adani Green share price: Stocks in the news: Adani Green, YES Bank, ICICI Lombard & Mindtree

YES Bank's board will meet on Friday to consider a proposal for further fundraising through various means.

Alembic (₹106.3): Buy - The Hindu BusinessLine - Vimarsana News

Alembic (₹106.3): Buy - The Hindu BusinessLine

Investors with a short term perspective can buy the stock of Alembic at current levels. The stock had encountered key resistance at around ₹120 in mid-September 2020 and was on a medium-term downtrend